Clinical Trial Update: TAS-102 in Treating Advanced Biliary Tract Cancers [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update for TAS-102 in advanced biliary tract cancers (cholangiocarcinoma and gallbladder cancer) has completed with results posted in 2…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cholangiocarcinoma
• Gallbladder Cancer

Drugs mentioned

• TAS-102 (trifluridine/tipiracil)

Snippet

Sponsor: Mayo Clinic | Conditions: Cholangiocarcinoma, Stage III Gallbladder Cancer AJCC v7 | Phase 2 | Status: COMPLETED | Results posted: 2019-10-01